Drugs Made In America Acquisition Corp. (DMAA)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 76
+0.01
+0.0465%
$
260.98M Market Cap
- P/E Ratio
- Div Yield
27,833 Volume
- Eps
$ 10.75
Previous Close Investors:
Want to track DMAA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Daniel L. Lippincott Karpus Management Inc. | 2.51M | $25.2M | $26.86M | $1.65M | 6.57% |
| BO Brian Oliveira Clear Street Group Inc. | 382,440 | $3.96M | $4.1M | $140,515.84 | 3.55% |
